News release

Former Alexandria Real Estate project and development services director joins JLL’s expanding life sciences team

Jenny Gardner has joined JLL as a director to lead on project and development services for life sciences

May 11, 2021

Jenny Gardner has joined JLL as a director to lead on project and development services for life sciences to advise clients on the viability and delivery of new projects.

Jenny spent 10-years in a senior project manager real estate developer role at Alexandria Real Estate Equities, the largest REIT specialising in life sciences where she contributed to the delivery of over 2m sq ft of life science focused assets in the USA. She joins JLL from Westfield in California where she has spent the last three years as retail delivery director.

JLL launched a dedicated life sciences team in 2019 with the appointment of Dr Glenn Crocker to respond to the recognition of the sector as a central pillar to UK economic growth. The team now comprises eight experienced professionals that work exclusively on life science and innovation projects.  Jenny will lead a team of project and cost management professionals as part of the 180-strong UK team bringing specific expertise to deliver both repositioning and development projects within the sector. 

The growing life sciences sector has seen investment in UK life science companies reach a record £2.8 billion in 2020 according to the BioIndustry Association, driving occupational demand in the sector. The sector is expanding across Europe with the UK at the forefront of this growth with a number of established clusters and hubs together employing over 250,000 scientists and professionals.

The UK’s ‘Golden Triangle’ of London, Oxford and Cambridge is a globally significant cluster of technology, life sciences, research and development that can compete internationally with the established hubs. According to BioCity the Golden Triangle produced just over 40% of life sciences start-ups between 2014 and 2018 and accounted for around 70% of start-up investment targeted at the sector. In addition to the Golden Triangle JLL has identified established life sciences markets in Manchester, Leeds, Nottingham, Edinburgh and Glasgow. Other cities including Bristol, Newcastle, Birmingham and Cardiff are beginning to see the life sciences sector emerge in their real estate markets.

Dr Glenn Crocker, head of life sciences at JLL, said: “Jenny’s experience of delivering life science facilities will enable us to further develop the services we provide to large and small pharma and biotech companies, investors and developers, universities and local authorities at a time when the sector in the UK is undergoing profound change and rapid expansion.”

Aimee Baker, head of UK project and cost consulting at JLL, said: “We are excited to welcome Jenny to the team and to be able to provide continuity of advice to our clients to realise the delivery of projects in this burgeoning sector.”

Jenny Gardner, project and development services director for life sciences at JLL, added: “I am thrilled to be on the front line of the rapidly-evolving and growing life science sector within the UK. With the support of the well-established teams and client partnerships within JLL, I strongly believe that we will be able to facilitate that growth on a grand scale, and I’m excited to use my skillset to bring best-in-class services to the industry.”


About JLL

JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $16.6 billion, operations in over 80 countries and a global workforce of more than 91,000 as of December 31, 2020. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.